Literature DB >> 28301927

Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.

Arnab Basu1, Gloria Komazin-Meredith1, Courtney McCarthy1, Aleksandar Antanasijevic2, Steven C Cardinale1, Rama K Mishra3, Dale L Barnard4, Michael Caffrey2, Lijun Rong5, Terry L Bowlin1.   

Abstract

Influenza A virus envelop protein hemagglutinin (HA) plays important roles in viral entry. We previously have reported that MBX2546, a novel influenza A virus inhibitor, binds to HA and inhibits HA-mediated membrane fusion. In this report, we show that (i) both binding and stabilization of HA by MBX2546 are required for the inhibition of viral infection and (ii) the binding of HA by MBX2546 represses the low-pH-induced conformational change in the HA, which is a prerequisite for membrane fusion. Mutations in MBX2546-resistant influenza A/PR/8/34 (H1N1) viruses are mapped in the HA stem region near the amino terminus of HA2. Finally, we have modeled the binding site of MBX2546 using molecular dynamics and find that the resulting structure is in good agreement with our results. Together, these studies underscore the importance of the HA stem loop region as a potential target for therapeutic intervention.

Entities:  

Keywords:  endosome; fusion; hemagglutinin; influenza A virus; inhibitor; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28301927      PMCID: PMC5458777          DOI: 10.1021/acsinfecdis.6b00194

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  28 in total

1.  H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes.

Authors:  R J Russell; S J Gamblin; L F Haire; D J Stevens; B Xiao; Y Ha; J J Skehel
Journal:  Virology       Date:  2004-08-01       Impact factor: 3.616

2.  Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.

Authors:  Erhard van der Vries; Foekje F Stelma; Charles A B Boucher
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Universal influenza virus vaccines: need for clinical trials.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Immunol       Date:  2014-01       Impact factor: 25.606

4.  Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.

Authors:  Aleksandar Antanasijevic; Arnab Basu; Terry L Bowlin; Rama K Mishra; Lijun Rong; Michael Caffrey
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

Review 5.  Structures of influenza A proteins and insights into antiviral drug targets.

Authors:  Kalyan Das; James M Aramini; Li-Chung Ma; Robert M Krug; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2010-04-11       Impact factor: 15.369

6.  Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Authors:  Tiffany G Sheu; Varough M Deyde; Rebecca J Garten; Alexander I Klimov; Larisa V Gubareva
Journal:  Antiviral Res       Date:  2009-11-01       Impact factor: 5.970

7.  New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.

Authors:  Arnab Basu; Aleksandar Antanasijevic; Minxiu Wang; Bing Li; Debra M Mills; Jessica A Ames; Peter J Nash; John D Williams; Norton P Peet; Donald T Moir; Mark N Prichard; Kathy A Keith; Dale L Barnard; Michael Caffrey; Lijun Rong; Terry L Bowlin
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

8.  Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion.

Authors:  J Zimmerberg; R Blumenthal; D P Sarkar; M Curran; S J Morris
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

9.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.

Authors:  T Danieli; S L Pelletier; Y I Henis; J M White
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

Review 10.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

View more
  7 in total

1.  Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.

Authors:  Xin Zhao; Runfeng Li; Yang Zhou; Mengjie Xiao; Chunlong Ma; Zhongjin Yang; Shaogao Zeng; Qiuling Du; Chunguang Yang; Haiming Jiang; Yanmei Hu; Kefeng Wang; Chris Ka Pun Mok; Ping Sun; Jianghong Dong; Wei Cui; Jun Wang; Yaoquan Tu; Zifeng Yang; Wenhui Hu
Journal:  J Med Chem       Date:  2018-06-11       Impact factor: 7.446

Review 2.  Influenza Virus Entry inhibitors.

Authors:  Jie Yang; Shuwen Liu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means.

Authors:  Olivier Terrier; Anny Slama-Schwok
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins.

Authors:  Ruikun Du; Han Cheng; Qinghua Cui; Norton P Peet; Irina N Gaisina; Lijun Rong
Journal:  Antiviral Res       Date:  2021-01-08       Impact factor: 5.970

5.  Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor.

Authors:  Aleksandar Antanasijevic; Matthew A Durst; Han Cheng; Irina N Gaisina; Jasmine T Perez; Balaji Manicassamy; Lijun Rong; Arnon Lavie; Michael Caffrey
Journal:  Life Sci Alliance       Date:  2020-07-01

6.  Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase.

Authors:  Lin Wang; Qinghua Cui; Xiujuan Zhao; Ping Li; Yanyan Wang; Lijun Rong; Ruikun Du
Journal:  Viruses       Date:  2019-07-20       Impact factor: 5.048

Review 7.  Small Molecule Inhibitors of Influenza Virus Entry.

Authors:  Zhaoyu Chen; Qinghua Cui; Michael Caffrey; Lijun Rong; Ruikun Du
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.